ELRIG's Drug Discovery 2026 is at ExCeL London on October 14 and 15, marking 20 years of the meeting.

We will be there to discuss hit and lead discovery programs, from fragment and compound screening through to hit-to-lead progression. 

Attending from Proteros:

Dr. Lars Neumann, Head of Hit & Lead Discovery Services
Dr. Jonas Noeske, Project Manager, supporting integrated early drug discovery programs
Dr. Sadaf Kasraie, VP, Strategic Business Development

Reach out to arrange a meeting.